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Chapter 9
Summary, discussion, conclusions and
perspectives
9.1 Summary
ln chapter 2.1-2.4 some methodological  problems of obtaining, processing
and evaluating bronchial biopsies were described. In chapter 3-5 the inflam-
matory data of our study on bronchial biopsies in nocturnal asthma were pre-
sented. Finally, in chapter 6-7 markers of inÍlammation in other body com-
panments were described, i.e. in exhaled air, serum and BAL Íluid.
Chapter 2.1 was directed to the problem of obtaining large and intact biop-
sies Írom the central airways. lt is known that bronchial biopsies are rather
small and that optimal biopsy technique is necessary to obtain high quality
tissue samples, as sufficient length of intact basement membrane and suffi-
cient depth of submucosal tissue are required. In this study, size and quali-
tative aspects of bronchial biopsies from non-asthmatic subjects, obtained by
forceps of three different sizes (types FB-19C, FB-21C and FB-35C) were
compared. We concluded that bronchial biopsies obtained with forceps type
FB-35C were the largest, but showed significant damage and crush artiÍacts.
In contrast, biopsies obtained with forceps type FB-21C were only slightly
smaller and had more intact basement membrane, more submucosal depth
and well preserved morphology. Therefore, forceps type FB-21C was used in
further studies of this thesis.
ln chapter 2.2 inÍlammatory cell counts in sections oÍ Íresh trozen and glycol
methacrylate (GMA)-embedded biopsies were compared. An important
advantage oÍ GMA embedding is its better morphology, although the main
impression is that its lower antigenicity may be a problem. Indeed lower num-
bers oÍ CD3-, CD4- and CD8-positive cells were counted in GMA-embedded
biopsies as compared to snap-frozen biopsies. In addition, only a weak cor-
relation between CD3-, CD4- and CD8-positive cellcounts oÍ both techniques
was observed, which we we supposed to be caused by an ongoing loss of
antigenic properties during storage of plastic-embedded tissue. An addition-
al study conÍirmed that CD3-, CD4- and CD8-positive cell numbers decrease
significantly within a Íew months after embedding in glycol methacrylate.
Therefore, we recommended to process glycol methacrylate-embedded
biopsies as soon as possible. Further, we considered Írozen tissue to be pre-
ferred in the quantitative evaluation oÍ inflammatory cells (like CD3, CD4,




other hand, glycol methacrylate-embedded tissue shows superior morpho-
logy and seems attractive to study qualitative aspects as cell-cell and cell-
matrix relationshios.
ln chapter 2.3 we evaluated the amount oÍ tissue that is necessary to produ-
ce constant cell counts in frozen sections oÍ bronchial biopsies. we formula-
ted this question because immunopostive cells are present in varying densi-
t ies in lung t issue, even within a sect ion oÍ a bronchial  biopsy. CD4-, CDg-
and EG2-immuno posit ive cel ls in bronchial  biopsies of f ive healthy and f ive
asthmatic subjects were evaluated. Twenty successive areas of 0.1 x 0.1-mm
submucosa were counted, and changes larger than 10 "Á were recorded. We
demonstrated that the cumulat ive count ing of 1O areas oÍ 0.1 x 0.1-mm along
1 mm intact basement membrane is sufÍicient to obtain constant cell numbers
(per area), provided that a proper selection of a representative part of the
biopsy has been made. Also, it appeared that volume artefacts and presen-
ce of smooth muscle and glands were responsible Íor the observed changes
in cel l  number above 10% aÍter count ing 1-mm basement membrane.
ln chapter 2.4lhe semi-quantitative and quantitative way oÍ evaluating in-
flammatory cells in bronchial biopsies were compared. Fresh frozen airway
biopsies of 7 asthmatic and 7 healthy subjects were immunostained for cD3,
CD4, CD8, CD25 and EG2 ant igen, and examined in a quant i tat ive and semi-
quantitative way. This study demonstrated that both methods correlated in
the evaluat ion of cD4-, cD8-, and EG2-immunopost ive c l ls.  The quant i tat i -
ve method showed a higher density of cD8- and cD25-positive cells in biop-
sies of asthmatic subjects as compared to healthy subjects, whereas the
semi-quantitative method showed a relatively higher density of CD3- and
cD4-positive cells. This partial agreement may be explained by the intrinsic
features oÍ the two methods. The semi-quantitative method includes the
deeper and larger parts of the biopsy, and has the advantage that biopsies of
lower morphological quality do not have to be discarded. In contrast, the
quantitative method includes only small parts of the biopsy (generally the
superÍicial layers) selected on basis oÍ integrity oÍ the tissue and absence of
smooth muscles and glandular epi thel ium. we concluded that with high cel l
density the semi-quantitative method is more useful, whereas with low cell
density the quantitative method may be preÍerred.
ln chapter 3 we tested the hypothesis that bronchial biopsies of subjects with
nocturnal asthma have more inflammatory cells at night than at daytime, in
contrast to subjects without nocturnal asthma. we recruited 13 healthy con-
trols, 15 atopic asthmatic patients with PEF-variation < is"/" and 1o atopic
asthmatic patients with PEF-variation > 1s"/". Bronchial biopsies were obtai-
ned at 16 h and 4 h, with an interval  of  1-2 weeks. Bronchial  biopsies were
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Summarv. discussion. conclusions and oersoect ives
(chapter 4),  |NOS expression (chapter 5) and vascular eNOS expression
(chapter 6).
The number of CD3-, CD4-, CD8-, CD25-, AA1 (tryptase)- and EG2- immu-
noposit ive cel ls in the submucosa did not increase at night in any of the three
groups. The number of EG2-positive cells in the two asthmatic groups was
signif icant ly higherthan in healthy controls,  both at 16 h and 04 h. The num-
ber of EG2-, CD4- and CD25-positive cells at 04 and at 16 h tended to be
higher in asthmatics with a PEF variat ion >'15% as compared to asthmatics
with PEF variation < 15"/". We concluded that increased nocturnal airway
obstruction is not caused by increased numbers oÍ inÍlammatory cells in the
bronchial  submucosa t  night.
Because vascular adhesion molecules are thought to be important for the
recruitment of inÍlammatory cells in the process oÍ asthmatic airway inflam-
mation, we hypothesized in chapter 4 that adhesion molecules are expressed
more extensively at night than at daytime in subjects with nocturnal asthma.
Biopsies were double- immunostained Íor CD31 in combinat ion with P-selec-
t in,  E-select in,  ICAM-1 or VCAM-1. We Íound no signi f icant day-night di f fe-
rences in expression of adhesion molecules in any of the three groups. The
expression oÍ VCAM-1 in biopsies oÍ asthmatic patients was signiÍicantly
higher than in biopsies oÍ healthy controls:  4.5 vs 2.5 "/"  at  16 h and 11 vs
0 "k al04 h. In asthma, VCAM-1 expression was positively correlated with
the number of EG2- and CD25-posit ive cel ls both at 16 h and 04 h, sug-
gesting a role for VCAM-1 in the ongoing airway wall inflammation of asthma.
Because Nitr ic Oxide (NO) may be involved in the pathogenesis of asthma-
tic airway inflammation, we hypothesized in chapter 5that the inducible Íorm
oÍ NO synthase ( |NOS) is upregulated at night in bronchial  biopsies of
pat ients with nocturnal asthma. Biopsies were immunostained with a poly-
clonal ant ibody against iNOS. We demonstrated that the expression of iNOS
in the bronchial wall was not increased at night in the asthmatic patients with
increased nocturnal airway obstruction, nor in the other subjects. Moreover,
biopsies of asthmatic patients more Írequently contained iNOS positive cells
than those of healthy conlrols, both at 16 and 04 h. In contrast to reports in
the l i terature, iNOS immunoreact iv i ty in the epithel ium was very sparse and
seemed mainly located in migrat ing inf lammatory cel ls and not in epithel ial
cells. Interestingly, epithelial and endothelial iNOS positivity at 04 h was
accompanied by a higher degree of submucosal EG2 positivity. We conclu-
ded that nocturnal asthma can not be explained by circadian variations in
iNOS exoression and that increased exoression of iNOS and EG2-oositive
cel ls probably represent a common underly ing mechanism.
ln chapter 6 the variable or constant presence oÍ endothelial NO synthase in
bronchial biopsies oÍ subjects with and without nocturnal asthma was stu-
died. Biopsies obtained at '16 and 4 h were double- immunostained for eNOS
1 1 9
Chapter 9
in combinat ion with a common endothel ial  ant igen (CD31). The degree of
immunopositivity Íor eNOS was evaluated and expressed as the percentage
of CD31 positive vessels encountered in complete sections oÍ a biopsy. The
mean (SD) 16-04 h changes in % eNOS expression in biopsies oÍ healthy
controls, asthmatic patients with mild and severe nocturnal airway obstruc-
t ion di f fered signi f icant ly:  17 @$, -14 (24) and +1 3 (27) %. Moreover,  the 16-
04 h change in eNOS expression in biopsies oÍ asthmatic subjects signi f i -
cantly correlated with PEF variation. We concluded that patients with large
swings in airway diameter lack the normal ly occurr ing increase in eNOS
expression at night.
As Nitr ic Oxide in exhaled air  may ref lect airway inf lammation we hypothesi-
zed in chapter 7 ïhaï subjects with nocturnal asthma show a circadian rhythm
in exhaled Nitr ic Oxide, inverse to the circadian rhythm in airway obstruct ion.
We measured NO concentrat ion together with FEVI a|12, 16,20,24, 4, B
and 12 h in 6 healthy controls, 8 asthmatics without and 6 asthmatics with
increased nocturnal airway obstruction. Exhaled NO did not show a signiÍi-
cant circadian variation in any of the three groups as assessed by cosinor
analysis ( in contrast o the FEVl in both asthma groups).  However,  exhaled
NO concentrat ion at 4 h was higher than at 16 h in subjects with nocturnal
asthma; otherwise values at al l  t ime points were simi lar.  Mean NO concen-
trat ion was signi Í icant ly higher in subjects with nocturnal asthma than in sub-
jects without nocturnal asthma and higher again than in healthy controls,  at
al l  t ime points.  Moreover,  mean NO levels over 24 hours correlated with 16-
4 h PEF variat ion in the asthmatic group. We concluded that subjects with
nocturnal asthma exhale higher NO levels during the whole day, suggest ing
more severe airway wall inÍlammation than subjects without nocturnal
asthma.
ln chapter 8 we studied the relationship between important cytokines in
serum and BAL f luid and cl in ical  maniÍestat ion oÍ atopic asthma. lL-4, lL-5
and IFN-y levels oÍ serum and BAL Í luid (obtained at 16 and 04 h) were
determined in 17 atopic asthmatics and I non-atopic healthy subjects, parti-
c ipat ing in another study on nocturnal asthma. Serum IFN-y increased signi-
f icant ly at night in asthmatic subjects.  Serum lL-4, lL-5 and IFN-y levels in
asthmatic subjects were signi f icant ly higher than in healthy controls,  both at
16 and 04 h. In asthmatic subjects,  serum IFN-yat both t ime points correla-
ted negat ively with PC26 methachol ine and posit ively with the mean 16-04 h
PEF variation. In contrast, no relationship was Íound between the serum
levels of lL-4 and lL-5 and the parameters of c l in ical  manifestat ion of asthma.
BAL Í luid levels of lL-4, lL-5 and IFN-y were Írequent ly below the level of
detect ion, may be as a consequence oÍ di lut ion. We concluded that serum
IFN-y levels may indicate the severity of airway wall inflammation in subjects
with atopic asthma. We suggested a.o. epi thel ial  cel ls to be the cel lular sour-
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